Back to Search Start Over

GTC Biotherapeutics Reports Launch of ATryn® in the U.S. by Lundbeck Inc

Source :
Business Wire. May 6, 2009
Publication Year :
2009

Abstract

FRAMINGHAM, Mass. -- ATryn(®) (Antithrombin [Recombinant]) is now available commercially through Lundbeck Inc. of Deerfield, IL, a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), [...]

Subjects

Subjects :
H. Lundbeck A/S -- Product introduction
GTC Biotherapeutics Inc. -- Product introduction
Biological products industry -- Product introduction
Pharmaceutical industry -- Product introduction
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.199105641

Tools

Authors Abstract Subjects Details